Published in Mol Cell Biol on July 01, 1990
Immunity to retroviral infection: the Friend virus model. Proc Natl Acad Sci U S A (1997) 2.28
GATA-1 directly regulates p21 gene expression during erythroid differentiation. Cell Cycle (2010) 2.17
Human endogenous retroviruses: nature, occurrence, and clinical implications in human disease. Clin Microbiol Rev (1996) 2.14
Retroviral insertions downstream of the heterogeneous nuclear ribonucleoprotein A1 gene in erythroleukemia cells: evidence that A1 is not essential for cell growth. Mol Cell Biol (1992) 1.70
Spi-1/PU.1 transgenic mice develop multistep erythroleukemias. Mol Cell Biol (1996) 1.63
Suppression of acute anti-friend virus CD8+ T-cell responses by coinfection with lactate dehydrogenase-elevating virus. J Virol (2007) 1.50
Cell cycle analysis of p53-induced cell death in murine erythroleukemia cells. Mol Cell Biol (1993) 1.48
Characterization of a live-attenuated retroviral vaccine demonstrates protection via immune mechanisms. J Virol (1998) 1.39
Mutant p53 tumor suppressor alleles release ras-induced cell cycle growth arrest. Mol Cell Biol (1991) 1.39
Growth suppression of Friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobin production and is sensitive to erythropoietin. Mol Cell Biol (1993) 1.38
Lymphocyte deficiencies increase susceptibility to friend virus-induced erythroleukemia in Fv-2 genetically resistant mice. J Virol (1999) 1.32
Fli-1, an Ets-related transcription factor, regulates erythropoietin-induced erythroid proliferation and differentiation: evidence for direct transcriptional repression of the Rb gene during differentiation. Mol Cell Biol (1999) 1.28
Expression of wild-type p53 is not compatible with continued growth of p53-negative tumor cells. Mol Cell Biol (1991) 1.25
Inactivation of p53 gene in human and murine osteosarcoma cells. Br J Cancer (1992) 1.24
c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Proc Natl Acad Sci U S A (1994) 1.19
Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalization of human keratinocytes but does not have E6-associated trans-activation or transforming activity. J Virol (1992) 1.18
Kinetics of the development of protective immunity in mice vaccinated with a live attenuated retrovirus. J Virol (1999) 1.18
Effects of type I interferons on Friend retrovirus infection. J Virol (2006) 1.14
The transforming and suppressor functions of p53 alleles: effects of mutations that disrupt phosphorylation, oligomerization and nuclear translocation. EMBO J (1993) 1.13
Estrogen-induced apoptosis by inhibition of the erythroid transcription factor GATA-1. Mol Cell Biol (1996) 1.13
The level of friend retrovirus replication determines the cytolytic pathway of CD8+ T-cell-mediated pathogen control. J Virol (2007) 1.10
Apoptosis in erythroid progenitors deprived of erythropoietin occurs during the G1 and S phases of the cell cycle without growth arrest or stabilization of wild-type p53. Mol Cell Biol (1994) 1.08
Genetic determinants of feline leukemia virus-induced lymphoid tumors: patterns of proviral insertion and gene rearrangement. J Virol (1994) 1.07
Expression from the murine p53 promoter is mediated by factor binding to a downstream helix-loop-helix recognition motif. Proc Natl Acad Sci U S A (1991) 1.06
Large-scale identification of disease genes involved in acute myeloid leukemia. J Virol (2004) 1.02
Role of interleukin-4 (IL-4), IL-12, and gamma interferon in primary and vaccine-primed immune responses to Friend retrovirus infection. J Virol (2001) 1.01
Temporal effects of gamma interferon deficiency on the course of Friend retrovirus infection in mice. J Virol (2002) 1.01
Protection against establishment of retroviral persistence by vaccination with a live attenuated virus. J Virol (1999) 1.00
Functional interference between the Spi-1/PU.1 oncoprotein and steroid hormone or vitamin receptors. EMBO J (1993) 0.98
Moloney murine leukemia virus-induced lymphomas in p53-deficient mice: overlapping pathways in tumor development? J Virol (1996) 0.92
Reprogramming leukemia cells to terminal differentiation and growth arrest by RNA interference of PU.1. Mol Cancer Res (2007) 0.92
Friend Spleen Focus-Forming Virus Activates the Tyrosine Kinase sf-Stk and the Transcription Factor PU.1 to Cause a Multi-Stage Erythroleukemia in Mice. Viruses (2010) 0.91
Modulation of immortalizing properties of human papillomavirus type 16 E7 by p53 expression. J Virol (1991) 0.90
Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic mice. J Virol (2001) 0.89
Humoral immunity in the Friend retrovirus infection model. Immunol Res (2013) 0.87
p45(NFE2) is a negative regulator of erythroid proliferation which contributes to the progression of Friend virus-induced erythroleukemias. Mol Cell Biol (2001) 0.84
Multi-stage Friend murine erythroleukemia: molecular insights into oncogenic cooperation. Retrovirology (2008) 0.84
P53 inhibition exacerbates late-stage anthracycline cardiotoxicity. Cardiovasc Res (2014) 0.83
Self-renewal of leukemia stem cells in Friend virus-induced erythroleukemia requires proviral insertional activation of Spi1 and hedgehog signaling but not mutation of p53. Stem Cells (2012) 0.81
Mutation of the endogenous p53 gene in cells transformed by HPV-16 E7 and EJ c-ras confers a growth advantage involving an autocrine mechanism. EMBO J (1994) 0.79
Differentiation arrest and stromal cell-independent growth of murine erythroleukemia cells are associated with elevated expression of ets-related genes but not with mutation of p53. Mol Cell Biol (1993) 0.76
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science (1988) 220.77
Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene (1985) 213.67
A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology (1973) 127.36
Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res (1984) 86.56
Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor. Cell (1978) 19.44
Monoclonal antibodies specific for simian virus 40 tumor antigens. J Virol (1981) 15.59
Mutations in the p53 gene occur in diverse human tumour types. Nature (1989) 13.62
Functional inactivation of genes by dominant negative mutations. Nature (1987) 13.12
The p53 proto-oncogene can act as a suppressor of transformation. Cell (1989) 11.67
Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science (1989) 11.53
Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose. Cell (1986) 8.87
p53: a frequent target for genetic abnormalities in lung cancer. Science (1989) 7.51
Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation. Nature (1985) 7.07
Participation of p53 cellular tumour antigen in transformation of normal embryonic cells. Nature (1985) 6.86
Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol Cell Biol (1988) 6.44
Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53. Nature (1985) 5.69
Wild-type p53 can inhibit oncogene-mediated focus formation. Proc Natl Acad Sci U S A (1989) 5.40
Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation. J Virol (1989) 4.63
Rearrangement of the p53 gene in human osteogenic sarcomas. Proc Natl Acad Sci U S A (1987) 4.21
Monoclonal antibody analysis of p53 expression in normal and transformed cells. J Virol (1986) 3.72
Spi-1 is a putative oncogene in virally induced murine erythroleukaemias. Nature (1988) 3.59
A method to detect and characterize point mutations in transcribed genes: amplification and overexpression of the mutant c-Ki-ras allele in human tumor cells. Proc Natl Acad Sci U S A (1985) 3.29
Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene. Cell (1984) 3.05
Identification of the p53 protein domain involved in formation of the simian virus 40 large T-antigen-p53 protein complex. J Virol (1986) 3.04
Immunological evidence for the association of p53 with a heat shock protein, hsc70, in p53-plus-ras-transformed cell lines. Mol Cell Biol (1987) 3.01
Precise epitope mapping of the murine transformation-associated protein, p53. EMBO J (1985) 2.98
Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus. Nature (1985) 2.98
Meth A fibrosarcoma cells express two transforming mutant p53 species. Oncogene (1988) 2.71
Immortalization of rat embryo fibroblasts by the cellular p53 oncogene. Oncogene (1988) 2.53
High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene. Mol Cell Biol (1989) 2.45
Cloning and expression analysis of full length mouse cDNA sequences encoding the transformation associated protein p53. Nucleic Acids Res (1984) 2.28
Cloning and characterization of a cDNA from Xenopus laevis coding for a protein homologous to human and murine p53. Oncogene (1987) 2.26
The cellular oncogene p53 can be activated by mutagenesis. Nature (1985) 1.99
Inactivation of the p53 oncogene by internal deletion or retroviral integration in erythroleukemic cell lines induced by Friend leukemia virus. Oncogene (1988) 1.96
Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia. Proc Natl Acad Sci U S A (1989) 1.86
Deletion of 5'-coding sequences of the cellular p53 gene in mouse erythroleukemia: a novel mechanism of oncogene regulation. Mol Cell Biol (1987) 1.69
Characterization of mutant p53-hsp72/73 protein-protein complexes by transient expression in monkey COS cells. Mol Cell Biol (1988) 1.48
Multistage Friend erythroleukemia: independent origin of tumor clones with normal or rearranged p53 cellular oncogenes. J Virol (1987) 1.32
Loss of a highly conserved domain on p53 as a result of gene deletion during Friend virus-induced erythroleukemia. Oncogene (1988) 1.28
Integration of Friend murine leukemia virus into both alleles of the p53 oncogene in an erythroleukemic cell line. J Virol (1988) 1.10
Regulation of PTEN transcription by p53. Mol Cell (2001) 5.44
Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr Biol (1998) 4.59
Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus. Nature (1985) 2.98
p53: oncogene or anti-oncogene? Genes Dev (1990) 2.60
Immortalization of rat embryo fibroblasts by the cellular p53 oncogene. Oncogene (1988) 2.53
Isolation and characterization of a human p53 cDNA clone: expression of the human p53 gene. EMBO J (1984) 2.45
Pidd, a new death-domain-containing protein, is induced by p53 and promotes apoptosis. Nat Genet (2000) 2.31
Transcriptional repression mediated by the p53 tumour suppressor. Cell Death Differ (2003) 2.30
Radioimmunoassay of the cellular protein p53 in mouse and human cell lines. EMBO J (1982) 2.29
Isolation and characterization of full-length functional cDNA clones for human carcinoembryonic antigen. Mol Cell Biol (1987) 1.99
Inactivation of the p53 oncogene by internal deletion or retroviral integration in erythroleukemic cell lines induced by Friend leukemia virus. Oncogene (1988) 1.96
Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia. Proc Natl Acad Sci U S A (1989) 1.86
Pten (phosphatase and tensin homologue gene) haploinsufficiency promotes insulin hypersensitivity. Diabetologia (2006) 1.72
Deletion of 5'-coding sequences of the cellular p53 gene in mouse erythroleukemia: a novel mechanism of oncogene regulation. Mol Cell Biol (1987) 1.69
Translational regulation of human p53 gene expression. EMBO J (1996) 1.41
Growth suppression of Friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobin production and is sensitive to erythropoietin. Mol Cell Biol (1993) 1.38
Participation of the human p53 3'UTR in translational repression and activation following gamma-irradiation. EMBO J (1997) 1.37
p53-dependent pathways of apoptosis. Cell Death Differ (2001) 1.34
Multistage Friend erythroleukemia: independent origin of tumor clones with normal or rearranged p53 cellular oncogenes. J Virol (1987) 1.32
Mutator phenotype in Msh2-deficient murine embryonic fibroblasts. Cancer Res (1997) 1.31
Loss of a highly conserved domain on p53 as a result of gene deletion during Friend virus-induced erythroleukemia. Oncogene (1988) 1.28
Presence of a heterozygous substitution and its relationship to DT-diaphorase activity. Br J Cancer (1995) 1.28
Expression of wild-type p53 is not compatible with continued growth of p53-negative tumor cells. Mol Cell Biol (1991) 1.25
From telomere loss to p53 induction and activation of a DNA-damage pathway at senescence: the telomere loss/DNA damage model of cell aging. Exp Gerontol (1996) 1.22
Structure and functionality of a designed p53 dimer. J Mol Biol (2001) 1.19
Protein-tyrosine phosphatase alpha regulates Src family kinases and alters cell-substratum adhesion. J Biol Chem (1998) 1.14
The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy. Radiother Oncol (1996) 1.14
The transforming and suppressor functions of p53 alleles: effects of mutations that disrupt phosphorylation, oligomerization and nuclear translocation. EMBO J (1993) 1.13
Analysis of genomic integrity and p53-dependent G1 checkpoint in telomerase-induced extended-life-span human fibroblasts. Mol Cell Biol (1999) 1.08
The core promoter region of the P-glycoprotein gene is sufficient to confer differential responsiveness to wild-type and mutant p53. Oncogene (1993) 1.07
A translation repressor element resides in the 3' untranslated region of human p53 mRNA. Oncogene (1999) 1.04
Mutation of the p53 gene in human acute myelogenous leukemia. Blood (1991) 1.03
Hemoglobin genes in non-legumes: cloning and characterization of a Casuarina glauca hemoglobin gene. Plant Mol Biol (1991) 1.03
Metaplasia of smooth muscle cells into juxtaglomerular cells in the juxtaglomerular apparatus, arteries, and arterioles of the ischemic (endocrine) kidney. An ultrastructural-cytochemical and autoradiographic study. Am J Pathol (1977) 1.03
Ultrasonic biomicroscopy of viable, dead and apoptotic cells. Ultrasound Med Biol (1997) 1.02
Expression of the p53 oncogene in acute myeloblastic leukemia. J Exp Med (1986) 1.01
Transformation associated p53 protein is encoded by a gene on human chromosome 17. Somat Cell Mol Genet (1985) 1.01
Hsp27 silencing coordinately inhibits proliferation and promotes Fas-induced apoptosis by regulating the PEA-15 molecular switch. Cell Death Differ (2011) 0.92
Abnormalities of the ARF-p53 pathway in oral squamous cell carcinoma. Oncogene (2001) 0.91
Cytokines inhibit p53-mediated apoptosis but not p53-mediated G1 arrest. Mol Cell Biol (1995) 0.91
Ultrastructural cytochemistry of atrial muscle cells. V. Characterization of specific granules in the human left atrium. J Ultrastruct Res (1975) 0.91
Identification of a human cancer related organ-specific neoantigen. Microbiol Immunol (1993) 0.91
Post-translational modification of p53 protein in response to ionizing radiation analyzed by mass spectrometry. J Mol Biol (2000) 0.90
The p53-mediated G1 checkpoint is retained in tumorigenic rat embryo fibroblast clones transformed by the human papillomavirus type 16 E7 gene and EJ-ras. Mol Cell Biol (1995) 0.90
Friend virus induced murine erythroleukaemia: the p53 locus. Cancer Surv (1992) 0.90
p53 mutations, c-myc and bcl-2 rearrangements in human non-Hodgkin's lymphoma cell lines. Leuk Lymphoma (1995) 0.89
Abnormal DNA content in oral epithelial dysplasia is associated with increased risk of progression to carcinoma. Br J Cancer (2010) 0.89
Transcription of genes of the carcinoembryonic antigen family in malignant and nonmalignant human tissues. Cancer Res (1988) 0.89
Alternative pathways for the extension of cellular life span: inactivation of p53/pRb and expression of telomerase. Oncogene (1999) 0.88
Expression of the cellular p53 protein in cells transformed by adenovirus 12 and viral DNA fragments. Virology (1988) 0.87
The role of p53 in tumor progression. Semin Cancer Biol (1994) 0.86
The expression of p53-induced protein with death domain (Pidd) and apoptosis in oral squamous cell carcinoma. Br J Cancer (2007) 0.86
P53-transformation-related protein: kinetics of synthesis and accumulation in SV40-infected primary mouse kidney cell cultures. Virology (1985) 0.84
Comparative analysis of the involvement of p53, c-myc and c-fos in epidermal growth factor-mediated signal transduction. Exp Cell Res (1987) 0.83
Ultrastructural radioautography of synthesis and migration of proteins and catecholamines in the rat adrenal medulla. Cell Tissue Res (1982) 0.83
Bacteriophage lambda DNA packaging in vitro. The involvement of the lambda FI gene product, single-strand DNA, and a novel lambda-directed protein in the packaging reaction. J Biol Chem (1982) 0.83
Localization and characterization of carbohydrates in adrenal medullary cells. J Cell Biol (1975) 0.82
Phosphorylation of p53 protein in response to ionizing radiation occurs at multiple sites in both normal and DNA-PK deficient cells. Oncogene (1999) 0.82
Inhibition of p53 expression by peptide-conjugated phosphorodiamidate morpholino oligomers sensitizes human cancer cells to chemotherapeutic drugs. Oncogene (2011) 0.81
Mutant p53 increases radioresistance in rat embryo fibroblasts simultaneously transfected with HPV16-E7 and/or activated H-ras. Oncogene (1994) 0.81
A functional wild-type p53 gene is expressed in human acute myeloid leukemia cell lines. Blood (1998) 0.81
Impaired TNFalpha-induced A20 expression in E1A/Ras-transformed cells. Br J Cancer (2009) 0.80
p53-mediated cell cycle arrest and apoptosis. Leukemia (1997) 0.80
Metaplastic and mitotic activity of the ischemic (endocrine) kidney in experimental renal hypertension. Am J Pathol (1979) 0.79
On the lysosomal function of juxtaglomerular granules. Beitr Pathol (1977) 0.79
Ultrastructural radioautography of the incorporation of tritiated leucine by the rat adrenal medulla in vivo. Cell Tissue Res (1978) 0.79
Mutation of the endogenous p53 gene in cells transformed by HPV-16 E7 and EJ c-ras confers a growth advantage involving an autocrine mechanism. EMBO J (1994) 0.79
Comparative ultrastructural cytochemistry of juxtaglomerular cell granules and renal tubular cell lysosomes. Lab Invest (1975) 0.79
Transforming activity of mutant human p53 alleles. J Cell Physiol (1991) 0.78
A novel endonuclease specified by bacteriophage lambda. Purification and properties of the enzyme. J Biol Chem (1982) 0.78
Alterations of p53 and c-myc in the clonal evolution of malignant lymphoma. Blood (1994) 0.78
Ultrastructural cytochemistry of atrial muscle cells. III. Reactivity of specific granules in man. Histochemistry (1974) 0.78
P-glycoprotein and tumor progression. J Natl Cancer Inst (1994) 0.77
Introduction of new genetic material into human myeloid leukemic blast stem cells by retroviral infection. Mol Cell Biol (1988) 0.77
Studies on HSAG, a middle repetitive family of genetic elements which elicit a leukemia-related cellular surface antigen. Nucleic Acids Res (1986) 0.76
Synergism between pairs of immortalizing genes in transformation assays of rat embryo fibroblasts. Oncogene (1990) 0.76
Relationship of specific granules to renin activity in the myocardium. Adv Myocardiol (1982) 0.76
Radioresistant MTp53-expressing rat embryo cell transformants exhibit increased DNA-dsb rejoining during exposure to ionizing radiation. Oncogene (1998) 0.76
p53 protein expression or protein function? Int J Radiat Oncol Biol Phys (1996) 0.75
The role of the bacteriophage lambda Fl gene product during phage head assembly in vitro. Virology (1978) 0.75
Elm bark derived feeding stimulants for the smaller European elm bark beetle. Science (1970) 0.75
The ben gene of bacteriophage lambda. Mapping, identification and control of synthesis. J Mol Biol (1982) 0.75
The Fi-gene product of bacteriophage lambda. Purification and properties. Eur J Biochem (1982) 0.75
A transcript exhibiting homology to endogenous rat retroviral-like elements is regulated by p53. Oncogene (1996) 0.75
Ultrastructural cytochemistry of the human adrenal medulla. Histochemistry (1977) 0.75
Synthesis and migration of proteins and glycoproteins in juxtaglomerular cells of sodium-deficient rats. An ultrastructural radioautographic study. Cell Tissue Res (1982) 0.75
The use of monoclonal antibodies for selection of a low-abundance mRNA: p53. Biochem Soc Trans (1984) 0.75
Ultrastructural cytochemistry of atrial muscle cells. IX. Reactivity of specific granules in cultured cardiocytes. J Mol Cell Cardiol (1980) 0.75
P53-mediated radioresistance does not correlate with metastatic potential in tumorigenic rat embryo cell lines following oncogene transfection. Int J Radiat Oncol Biol Phys (1996) 0.75
The chemical nature of human atrial specific granules. Recent Adv Stud Cardiac Struct Metab (1975) 0.75
Ultrastructural cytochemistry of atrial muscle cells. VIII. Radioautographic study of synthesis and migration of proteins. Cell Tissue Res (1980) 0.75
Ultrastructural cytochemistry of atrial muscle cells. VII. radioautographic study of synthesis and migration of glycoproteins. J Mol Cell Cardiol (1979) 0.75